Understanding Pathophysiology
Why This Work Matters
Research has not advanced evenly across all 16p11.2 variants, leaving gaps in guidance and access. This can be uncomfortable for an organization, but we have chosen to lean into that discomfort and keep an open and respectful dialogue. As a parent- and volunteer-led organization, we work to address these gaps by translating current knowledge into practical care while expanding research, education, and resources.
Our mission is to support all individuals affected by 16p11.2 genetic variation. As the science advances, so will the guidance available to families and clinicians. Please help us advance the science forward for all of our children.
Learn how you can support this work by donating, volunteering, or contributing expertise.
How 16p11.2 Deletion Affects the Body
This page explains how a 16p11.2 deletion affects the body. It is written in clear, simple language so families, clinicians, and educators can understand what is happening and why early care matters.
What is a 16p11.2 deletion?
A 16p11.2 deletion means a small piece of chromosome 16 is missing. This missing section contains several genes that help guide early brain and body development.
Genes act like instruction manuals. When some pages are missing, development can still continue, but it may follow a different path.
Recent large‑scale studies show that individuals with 16p11.2 deletion are particularly sensitive to environmental and treatment factors. This means that while genetics shape risk, care decisions and supports play a significant role in long‑term outcomes.
What this understanding changes in practice
Understanding the biology and timing of 16p11.2 deletion supports:
- Taking parental concerns seriously even when exams look normal
- Repeating assessments at developmental transitions
- Ongoing seizure surveillance rather than one‑time clearance
- Coordinated, multisystem care across childhood and adolescence
- Honest counseling that balances hope with preparation
Care works best when it evolves as the child grows.
Genetics sets risk. Environment shapes outcomes.
Studies following hundreds of individuals across many genetic neurodevelopmental conditions show that external factors can meaningfully influence developmental outcomes. For 16p11.2 deletion in particular, environmental and treatment-related factors account for a larger share of variability in adaptive functioning than genetic diagnosis alone.
These factors include:
- Seizure duration and severity
- Hospitalization burden
- Medication exposure
- Access to early intervention and supportive services
- Family and socioeconomic stability
This helps explain why two children with the same deletion can have very different developmental trajectories.
Why babies often look typical at birth
Many babies with a 16p11.2 deletion look typical at birth. This happens because:
- Basic body structures usually form before birth
- Early newborn skills require fewer, simpler brain connections
Because of this, differences may not be obvious right away. This does not mean development will stay typical.
Why timing matters in 16p11.2 deletion
Research across genetic neurodevelopmental conditions now shows that many features do not appear all at once. Instead, risk unfolds over time as the brain and body take on more complex tasks. This matters for 16p11.2 deletion, where early development may look typical, but challenges can emerge later as demands on learning, behavior, emotional regulation, and physical health increase.
This means that 16p11.2 deletion should not be understood as a fixed diagnosis with a single outcome. It is an evolving condition where timing shapes how and when differences appear.
How development changes over time
As children grow, the brain must build more complex networks for:
- Speech and language
- Motor skills
- Learning and attention
- Emotional and behavioral control
With a 16p11.2 deletion, these networks may develop more slowly or in a different way. When early skills are delayed, later skills that depend on them are also affected.
This is why developmental gaps can grow over time if support is delayed.
Seizure care is a developmental issue, not only a neurologic one
Seizures occur in a subset of individuals with 16p11.2 deletion, but their impact goes beyond the seizure events themselves. Research shows that longer periods of uncontrolled seizures, higher treatment burden, and frequent hospitalizations are associated with lower adaptive functioning over time.
Importantly, these effects are not solely explained by the genetic condition. They reflect how neurological challenges interact with development during sensitive periods. This underscores the importance of:
- Ongoing seizure surveillance
- Thoughtful selection of treatments
- Minimizing unnecessary disruptions to daily life whenever possible
Early identification and careful management can help reduce downstream developmental impacts.
Why early absence of symptoms does not rule out later needs
Studies that follow individuals across childhood and adolescence show that the absence of seizures, learning difficulties, or mental health symptoms in early life does not mean those risks are gone. Instead, it often means the individual has not yet entered the developmental window when those systems are most stressed.
For children with 16p11.2 deletion, this explains why:
- Early evaluations can look reassuring
- New challenges may emerge later, especially at school transitions or during adolescence
- Repeat assessments are a sign of good care, not failure
This age‑aware understanding supports planned follow up rather than waiting for problems to become obvious.
Why early intervention is protective
Early intervention helps the brain during its most flexible stage.
Support such as speech therapy, occupational therapy, physical therapy, and educational services can:
- Strengthen brain connections
- Reduce the size of developmental gaps
- Improve long‑term learning and independence
Waiting to see if a child “catches up” will allow gaps to widen.
Why age‑aware care matters
Understanding that risk unfolds over time changes how care is delivered. Rather than asking whether a child has a specific diagnosis yet, clinicians can focus on:
- What systems are entering higher demand
- Which supports should be reassessed or added
- How to prevent gaps from widening at key transitions
This shifts care from reactive to preventive.
Why timing makes environment more powerful
Children with 16p11.2 deletion pass through predictable developmental windows when new systems come under stress, such as language expansion, academic demands, emotional regulation, and adolescence.
During these windows:
- The brain is actively reorganizing
- Small differences in support can compound over time
- Stressors can have outsized effects
This is why outcomes may diverge more sharply after early childhood, even when early development appeared to reassure.
Brain signaling and balance
Genes in the 16p11.2 region support how brain networks mature and communicate over time. When these genes are missing, brain signaling differences may not be fully apparent in infancy, when networks are simpler.
When these genes are missing, brain signaling can become unbalanced. This may affect timing and network maturation:
As the brain matures and networks must coordinate across longer distances for attention, learning, emotional regulation, and executive function, signaling differences become more visible. This helps explain why:
- Attention and focus
- Sensory processing
- Risk for anxiety, ADHD, or autism‑related traits
- Attention and anxiety symptoms often emerge later
- Emotional regulation challenges may increase with age
- Seizures can begin outside early childhood
This is a biological difference, not a behavioral choice.
Effects beyond the brain and multisystem effects unfold over time
Because every cell carries the deletion, effects are not limited to the brain. Research across copy number variants shows that multiple body systems can be involved, with timing that varies by system.
- Ongoing monitoring of growth, metabolism, and appetite
- Attention to puberty timing and hormonal changes
- Continued surveillance for sleep and neurologic changes into adolescence
- Immune function
- Muscle tone and coordination
This is why care should look at the whole child across development, not only during early childhood.
Why children can seem “less affected” than they are
A child may look typical during a short clinic visit but still struggle with:
- Fatigue
- Sleep problems
- Learning effort
- Emotional overload
- Multiple medical conditions happening at once
Families report that this mismatch between appearance and medical complexity is one of the hardest parts of living with 16p11.2 genetic variation.
Seizures and neurologic risk over time
Seizures occur in a subset of individuals with 16p11.2 deletion, but timing matters. Large genetic studies show that seizure risk can emerge later in childhood or adolescence, even when early EEGs are normal and no seizures occurred in infancy.
For families and clinicians, this means:
- Early normal testing does not close the chapter on seizure risk
- Periodic neurologic check ins are appropriate
- Education about warning signs should be revisited as children grow
This approach reduces surprise, prevents delayed diagnosis, and supports timely care.
Why treatment may involve off‑label care
There are currently no medications specifically approved for 16p11.2 deletion.
Treatment often focuses on managing symptoms using therapies and, when appropriate, carefully chosen medications based on how the brain and body systems are affected.
This is why understanding pathophysiology is essential.
Clinician notes
Early wiring and speed
In 16p11.2 deletion, early brain wiring can form with differences in connection strength and timing. Long range networks that support attention, language, and social learning may be less synchronized. In early childhood, this can look like “walking a little later” or “talking a little later,” but these small delays can signal that core building blocks are being laid down differently. Over time, later skills depend on earlier skills, so the developmental gap widens if support is delayed. Research in humans and mouse models supports altered functional connectivity and GABA related signaling changes in 16p11.2 deletion.
Pruning and refinement
As the brain develops, it normally prunes weaker or inefficient connections and keeps stronger ones. In 16p11.2 deletion, some studies suggest altered pruning signals, which may reduce normal clearing of extra cells or connections. This can contribute to brain overgrowth in some individuals and may affect network efficiency.
Perseveration and flexibility
With time and therapy, many skills are gained. However, some individuals show difficulty with flexibility, habit learning, or “getting stuck” in a pattern and processing speed. Basal ganglia circuit findings in 16p11.2 deletion mouse models include changes that can relate to repetitive behaviors and reduced habituation.
Excitation and inhibition balance
Across copy number variant syndromes, evidence suggests that excitation and inhibition balance can be disrupted. In 16p11.2 deletion models, some studies report reduced markers of inhibitory interneuron function and altered network connectivity. This can help explain sensory differences, attention variability, and vulnerability to anxiety or ADHD traits.
A translational pathway example
Several lines of work point to downstream signaling pathways that may be targetable. In mouse models, RHOA and ROCK pathway modulation has improved some learning and memory measures. In human iPSC derived dopaminergic neuron networks, hyperactivity linked to 16p11.2 deletion has been rescued in vitro by RHOA inhibition.
References for clinicians
- Altered prefrontal connectivity in human carriers and mouse model: Bertero et al., Brain (2018): https://academic.oup.com/brain/article/141/7/2055/4989322
- Large-scale analysis of epilepsy risk across copy number variants, including adolescent-onset risk: medRxiv preprint (2025). Data derived from aggregated human CNV cohorts, including Simons Searchlight:
https://www.medrxiv.org/content/10.64898/2025.11.29.25341264v1.full - Fronto temporal connectivity and GABA related dysfunction in 16p11.2 deletion mice: Openshaw et al., Communications Biology (2023): https://www.nature.com/articles/s42003-023-04891-2
- Basal ganglia circuit defects and reduced habituation in 16p11.2 deletion mouse model: Portmann et al., Cell Reports (2014): https://www.cell.com/cell-reports/fulltext/S2211-1247(14)00214-9
- Pruning related signal CD47 and reduced phagocytosis in 16p11.2 deletion iPSC derived cells: Li et al., (2021): https://www.jstor.org/stable/27040139
- Excitation and inhibition balance across CNV syndromes, systematic review: Sylvester et al., Journal of Neurodevelopmental Disorders (2025): https://link.springer.com/article/10.1186/s11689-025-09614-8
- RHOA pathway targeting in 16p11.2 deletion mouse models, fasudil rescue of recognition memory: Martin Lorenzo et al., Molecular Autism (2021): https://link.springer.com/article/10.1186/s13229-020-00405-7
- 16p11.2 deletion iPSC dopaminergic neuron network hyperactivity rescued by RHOA inhibition: Sundberg et al., Nature Communications (2021):
https://www.nature.com/articles/s41467-021-23113-z
What this understanding means for care
Understanding the biology of 16p11.2 deletion helps everyone involved to:
- Take parental concerns seriously
- Act early when milestones are missed
- Look at the whole child, not one symptom
- Set realistic and hopeful goals
With the right support, children with 16p11.2 deletion can learn, grow, and thrive.